Market Place
Sourcing Support
Sanofi $110 M Radioligand Therapy Hits Main Goal in Ph. 2 Trial
09 Oct 2025 //
PRESS RELEASE
Sanofi Inks Pact with Canadian Tech Company to Bring AI to R&D
09 Oct 2025 //
FIERCE BIOTECH
Biovaxys Appoints Former Sanofi Vaccines Executive to Board
08 Oct 2025 //
PR NEWSWIRE
Galderma`s Itch Relief Claims Scratched After Sanofi Complaint
08 Oct 2025 //
FIERCE PHARMA
Novavax Advances Sanofi Partnership With Nuvaxovid® EU Marketing
07 Oct 2025 //
PR NEWSWIRE
Revvity Unveils Initiative For Early Type 1 Diabetes Detection
02 Oct 2025 //
PHARMAWEB
Novavax Announces Progress On Sanofi Agreement
01 Oct 2025 //
PRESS RELEASE
Star Therapeutics Secures $125m In Series D Funding
30 Sep 2025 //
BUSINESSWIRE
Sanofi Under EU Investigation Over Vaccines
30 Sep 2025 //
REUTERS
Boryung Picks Up Taxotere Rights In Deal Worth Up To $205M
30 Sep 2025 //
FIERCE PHARMA
Sanofi Boosts Ventures With $625m For Biotech And Digital Health
27 Sep 2025 //
PRESS RELEASE
Sanofi Expands Price Cut To $35 Monthly For All Insulin Products
26 Sep 2025 //
FIERCE PHARMA
Immuneering Prices 175M Public Offering, Secures 25M in Placement
25 Sep 2025 //
GLOBENEWSWIRE
Press Release: Availability Of The Q3 2025 Aide Mémoire
24 Sep 2025 //
PRESS RELEASE
Sanofi Launches Ai-Powered Real Skinformation Site
23 Sep 2025 //
PHARMAWEB
Sanofi’s SAR446268 Gets Fast Track for Myotonic Dystrophy Type 1
23 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Dupixent® For Chronic Spontaneous Urticaria Gains
22 Sep 2025 //
GLOBENEWSWIRE
Sanofi, Regeneron`s Dupixent For Chronic Spontaneous Urticaria
22 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Oral Ms Drug FDA Action Date Shifted To December
22 Sep 2025 //
BIOSPACE
Update on the US Regulatory Review of Tolebrutinib in MS
22 Sep 2025 //
PRESS RELEASE
Sanofi`s Brivekimig Shows Positive Phase 2a Results
17 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Libtayo Combo Shows 5-Year Survival Gain in NSCLC
16 Sep 2025 //
INDPHARMAPOST
Sanofi becomes Latest Pharma to Hold fire on UK R&D Investments
16 Sep 2025 //
FIERCE BIOTECH
Sanofi: Total Voting Rights and Shares Update - August 2025
12 Sep 2025 //
GLOBENEWSWIRE
Sanofi Triumphs at 2025 Fierce Pharma Marketing Awards
11 Sep 2025 //
FIERCE PHARMA
Sanofi`s SAR402663 Granted Fast Track Status for Neovascular AMD
11 Sep 2025 //
PRESS RELEASE
Tzield Approved in China: 1st Therapy for Stage 2 Type 1 Diabetes
11 Sep 2025 //
PRESS RELEASE
Sanofi Creates `Celebrity Mom Squad` for Beyfortus RSV Drive
10 Sep 2025 //
FIERCE PHARMA
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
Onco360® Chosen as National Pharmacy Partner for Wayrilz
08 Sep 2025 //
GLOBENEWSWIRE
Expert Discusses Future Research and Definitions in CIDP Care
08 Sep 2025 //
FIERCE PHARMA
New Data across Sanofi’s Immunology Pipeline reinforce leadership
05 Sep 2025 //
PRESS RELEASE
Sanofi Ph 3 Eczema Win Falls Below Analyst Expectations
04 Sep 2025 //
FIERCE BIOTECH
Thermo Fisher Scientific Buys NJ Site from Sanofi
02 Sep 2025 //
PRESS RELEASE
Genzyme`s Wayrilz Receives Approval in US
29 Aug 2025 //
FDA
Sanofi`s Wayrilz FDA Approved as First BTK Inhibitor for Immune
29 Aug 2025 //
PRESS RELEASE
Sanofi Joins Report Spotlighting Community Health Workers
27 Aug 2025 //
FIERCE PHARMA
Sanofi snags BioMarin Leader to Serve as CMO
26 Aug 2025 //
FIERCE BIOTECH
Sanofi discloses total voting rights, shares for July 2025
18 Aug 2025 //
GLOBENEWSWIRE
First T1D Treatment Licensed for Stage 3 Delay in Adults and Kids
15 Aug 2025 //
PHARMAWEB
Response’s Ex-Sanofi Asset Hits Goal in Post-GLP-1 Patients
15 Aug 2025 //
FIECE BIOTECH
Sanofi`s Rilzabrutinib Granted EU Orphan Designation
14 Aug 2025 //
PRESS RELEASE
Sanofi Completes the Acquisition of Vigil Neuroscience
06 Aug 2025 //
PRESS RELEASE
Sanofi India Reports Rs. 60.7 Cr Pat in Q2 2025
05 Aug 2025 //
INDPHARMAPOST
Sanofi pens $395M China pact for Arrowhead Metabolic med
02 Aug 2025 //
PRESS RELEASE
Sanofi`s Avapro Receives Approval in US
01 Aug 2025 //
FDA
Sanofi’s SAR446523 Gets US Orphan Drug Tag For Multiple Myeloma
31 Jul 2025 //
PRESS RELEASE
Q4 Sales Up 10.3%, EPS Beats FY24, Rebound Expected in 2025
31 Jul 2025 //
PRESS RELEASE
Sanofi’s Sarclisa Approved in EU for Multiple Myeloma
25 Jul 2025 //
PRESS RELEASE
Sanofi Supports Film About Women`s Experiences with Hemophilia
24 Jul 2025 //
FIERCE PHARMA
Kyowa, Amgen, Sanofi Support Women`s Health Info Update
23 Jul 2025 //
FIERCE PHARMA
Sanofi to Buy Respiratory Vaccine Biotech Vicebio for $1.6 B
23 Jul 2025 //
PRESS RELEASE
Beyfortus Cuts RSV disease Visits by 87% in US Study
22 Jul 2025 //
PR NEWSWIRE
Sanofi Completes Acquisition of Blueprint Medicines
19 Jul 2025 //
PRESS RELEASE
Sanofi Extends Blueprint Tender Offer Period
17 Jul 2025 //
GLOBENEWSWIRE
Sanofi’s SAR446597 Earns Fast Track Designation in the US
17 Jul 2025 //
PRESS RELEASE
Thermo Fisher Snaps up Sanofi Fill-Finish Plant in New Jersey
17 Jul 2025 //
FIERCE PHARMA
Emcure, Sanofi ink Deal for Oral Anti-diabetic Products in India
17 Jul 2025 //
PRESS RELEASE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Sanofi Updates Total Voting Rights and Shares - June 2025
09 Jul 2025 //
GLOBENEWSWIRE
